• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.69% Nasdaq Up 0.44%

    Endocyte, Inc. (ECYT)

    -NasdaqGS
    5.04 Down 0.16(3.08%) Jul 29, 4:00PM EDT
    Add to Portfolio
    Prev Close:5.20
    Open:5.15
    Bid:4.90 x 1000
    Ask:6.48 x 700
    1y Target Est:12.25
    Beta:2.2
    Next Earnings Date:N/A
    Day's Range:4.96 - 5.21
    52wk Range:4.82 - 9.35
    Volume:253,241
    Avg Vol (3m):333,898
    Market Cap:211.33M
    P/E (ttm):N/A
    EPS (ttm):-0.06
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    ECYTDown 3.08%211.33M
    NKTRDown 5.51%1.60B
    RHHBYUp 0.05%245.78B
    SNSSUp 13.68%97.04M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):4.11
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.25
    Quarterly EPS Est (Jun-15) :-0.30
    Mean Recommendation*:2.2
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback